热门资讯> 正文
MediWound获得欧洲创新委员会1，625万欧元融资
2024-07-16 21:46
MediWound (NASDAQ:MDWD) said on Tuesday it has been selected to receive €16.25M in blended funding from the European Innovation Council through its accelerator program.
Shares of the company are up about 1.2% in early trade.
The funding will significantly advance the company’s EscharEx development program for patients with diabetic foot ulcers, MDWD said.
Pending FDA and EMA approval, the funding will enable the Company to expedite the market introduction of this biologic by four years, ahead of MediWound’s original schedule.
The funding package includes a €2.5 million grant and an investment, with terms to be finalized between the company and the EIC, MediWound said in a statement.
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
